Aberrant alternative splicing in breast cancer

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Alternative splicing significantly expands the human proteome's functional diversity.
• Aberrant alternative splicing is a recognized hallmark of cancer.
• Breast cancer remains a leading cause of cancer-related mortality in women globally.

Purpose of the Study:

• To review the intricate relationship between alternative splicing and breast cancer.
• To elucidate the regulatory role of alternative splicing in cancer.
• To explore therapeutic strategies targeting alternative splicing in breast cancer.

Main Methods:

• Literature review and synthesis of existing research.
• Analysis of statistical data on breast cancer and alternative splicing.
• Discussion of molecular mechanisms and clinical implications.

Main Results:

• Alternative splicing dysregulation is closely linked to breast cancer initiation and progression.
• Mutations in splicing factors contribute to aberrant splicing in breast cancer.
• Alternative splicing plays a role in therapeutic resistance in cancer.

Conclusions:

• Alternative splicing is a critical factor in breast cancer development and progression.
• Targeting aberrant alternative splicing presents a promising avenue for novel breast cancer therapeutics.
• Further research into splicing factor mutations and drug resistance mechanisms is warranted.